Skip to main content

Open Research Biopharmaceutical Internships Support

Objective

The current process of drug development is lengthy and inefficient. Only 1 out of approximately 10,000 drug molecules enters the market. Therefore more effective medicines, demanded by society, cannot be provided by pharmaceutical industry. To fill this gap, Open Research Biopharmaceutical Internships Support (ORBIS) proposes that the high attrition rate of new drug candidates might be reduced by over 20% by improving early stage R&D productivity. The overarching objective of ORBIS is therefore to form an international and inter-sectoral academic and industrial network. The action is aimed at improving the preclinical pathway of medicine development concentrating on processes and technologies. The goal is to integrate multidisciplinary research by involving academia and industry from EU (Poland, Ireland, Finland, Germany and Czech Republic), EU associated country (Ukraine) and US to address the poor drug bioavailability as 70% of actives have solubility and/or membrane permeability problems. The action is addressed at selected molecules of class II and IV of Biopharmaceutics Classification System, to improve their pharmaceutical potential. The complementary consortium comprises experts in computations, physical chemistry, material science, nanotechnology, pharmacy, pharmacology and bioanalysis. The secondments will create a stimulating environment for early stage researchers to advance their individual career and soft skills. EU scientists will amalgamate their expertise in drug synthesis and dissolution, oral formulations, and bioanalytical methods with the knowledge on dermal research provided by the US partner. ORBIS will consolidate the existing links, promote long-term cooperation and exchange of knowledge between beneficiaries and partners. ORBIS will also enhance dissemination of new research outcomes and raise the awareness among the general public of the importance of drug delivery research that makes new drugs more accessible and affordable for society.

Coordinator

UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU
Net EU contribution
€ 737 865,00
Address
Ul. Fredry 10
61-701 Poznan
Poland
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
Region
Makroregion północno-zachodni Wielkopolskie Miasto Poznań

Participants (11)

JOINT STOCK COMPANY FARMAK
Ukraine
Net EU contribution
€ 189 000,00
Address
63, Frunze Str.
04080 Kijev
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
Ireland
Net EU contribution
€ 99 000,00
Address
College Green Trinity College
D02 CX56 Dublin 2
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
SIEC BADAWCZA LUKASIEWICZ - INSTYTUT FARMACEUTYCZNY

Participation ended

Poland
Net EU contribution
€ 131 535,00
Address
Ul. Rydygiera 8
01 793 Warszawa
Activity type
Other
Non-EU contribution
€ 0,00
Region
Makroregion województwo mazowieckie Warszawski stołeczny Miasto Warszawa
PHYSIOLUTION GMBH
Germany
Net EU contribution
€ 45 000,00
SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Address
Walther-rathenau-strasse 49 A
17489 Greifswald
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
Region
Mecklenburg-Vorpommern Mecklenburg-Vorpommern Vorpommern-Greifswald
 
APPLIED PROCESS COMPANY LIMITED
Ireland
Net EU contribution
€ 4 500,00
SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Address
Building 11 Cherrywood Business Park Loughlinstown
D18DH50 Dublin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
Region
Ireland Eastern and Midland Dublin
 
HELSINGIN YLIOPISTO
Finland
Net EU contribution
€ 139 500,00
Address
Yliopistonkatu 3
00014 Helsingin Yliopisto
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
Region
Manner-Suomi Helsinki-Uusimaa Helsinki-Uusimaa
ZENTIVA, K.S.
Czechia
Net EU contribution
€ 332 100,00
Address
U Kabelovny 130
10237 Prague
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
Region
Praha Hlavní město Praha
 
POLITECHNIKA POZNANSKA
Poland
Net EU contribution
€ 319 500,00
Address
Pl Marii Sklodowskiej Curie 5
60 965 Poznan
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
Region
Makroregion północno-zachodni Wielkopolskie Miasto Poznań
UNIVERZA V LJUBLJANI
Slovenia
Net EU contribution
€ 135 000,00
Address
Kongresni Trg 12
1000 Ljubljana
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
VYSOKA SKOLA CHEMICKO-TECHNOLOGICKA V PRAZE
Czechia
Net EU contribution
€ 94 500,00
Address
Technicka 5
166 28 Praha
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
CELON PHARMA SA
Poland
Net EU contribution
€ 40 500,00
Address
Ulica Ogrodowa 2A
05 092 Kielpin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00

Partners (2)

Partner

Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.

RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
United States
Net EU contribution
€ 0,00
Address
Rutgers Plaza 3
08901 New Brunswick
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
Partner

Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.

UNIVERSITY OF CENTRAL FLORIDA
United States
Net EU contribution
€ 0,00
Address
Central Florida Blvd 4000
32816 Orlando
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00